Immunology
-
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
This article has 47 authors:Reviewed by ScreenIT
-
Ad26.COV2.S-elicited immunity protects against G614 spike variant SARS-CoV-2 infection in Syrian hamsters and does not enhance respiratory disease in challenged animals with breakthrough infection after sub-optimal vaccine dosing
This article has 27 authors:Reviewed by ScreenIT
-
Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reaction
This article has 46 authors:Reviewed by ScreenIT
-
Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
This article has 12 authors:Reviewed by Review Commons, ScreenIT
-
mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
This article has 19 authors:Reviewed by ScreenIT
-
SLAMF7 engagement super-activates macrophages in acute and chronic inflammation
This article has 13 authors:Reviewed by ScreenIT
-
Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy
This article has 27 authors:Reviewed by ScreenIT
-
Neuraminidase inhibitors rewire neutrophil function in vivo in murine sepsis and ex vivo in COVID-19
This article has 37 authors:Reviewed by ScreenIT
-
Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2
This article has 9 authors:Reviewed by ScreenIT
-
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
This article has 16 authors:Reviewed by ScreenIT